The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA

Journal of Biological Chemistry

Volumn 289, Issue 25, 2014, Pages 17350-17364

  Jacob, Aishwarya G ^a,b,c   Singh, Ravi K ^a,b   Mohammad, Fuad ^a,c   Bebee, Thomas W ^a,b   Chandler, Dawn S ^a,b,c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

ALTERNATIVE SPLICING; CIS-REGULATORY ELEMENTS; ELEMENT-BINDING PROTEINS; GENOTOXIC STRESS; NORMAL CONDITION; REGULATORY FACTORS; SPLICING FACTORS; SPLICING REACTIONS;

TRANSCRIPTION;

MESSENGER RNA PRECURSOR; PROTEIN MDM2;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAR UPSTREAM ELEMENT BINDING PROTEIN 1 GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; INTRON; ONCOGENE; ONCOGENE MDM2; PRIORITY JOURNAL; REGULATOR GENE; RNA SPLICING; SURVIVAL RATE; UPREGULATION;

CANCER; MDM2; ONCOGENE; P53; RNA; RNA SPLICING; RNA-BINDING PROTEIN; RNA-PROTEIN INTERACTION;

ALTERNATIVE SPLICING; DNA HELICASES; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; INTRONS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA PRECURSORS; TRANSCRIPTION FACTORS;

EID: 84903471466     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.554717     Document Type: Article

References (59)

1. Honda, R., Tanaka, H., and Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27 (Pubitemid 28037193)
2. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860 (Pubitemid 23132165)
3. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245
4. Fakharzadeh, S. S., Trusko, S. P., and George, D. L. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10, 1565-1569 (Pubitemid 21905621)
5. Momand, J., Jung, D., Wilczynski, S., and Niland, J. (1998) The MDM2 gene amplification database. Nucleic Acids Res. 26, 3453-3459 (Pubitemid 28347214)
6. Bartel, F., Taylor, A. C., Taubert, H., and Harris, L. C. (2001) Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines. Oncol. Res. 12, 451-457 (Pubitemid 33791805)
7. Kraus, A., Neff, F., Behn, M., Schuermann, M., Muenkel, K., and Schlegel, J. (1999) Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells. Int. J. Cancer 80, 930-934 (Pubitemid 29108870)
8. Sigalas, I., Calvert, A. H., Anderson, J. J., Neal, D. E., and Lunec, J. (1996) Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat. Med. 2, 912-917 (Pubitemid 26296763)
9. Sánchez-Aguilera, A., García, J. F., Sánchez-Beato, M., and Piris, M. A. (2006) Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control. Oncogene 25, 2565-2574
10. Lukas, J., Gao, D. Q., Keshmeshian, M., Wen, W. H., Tsao-Wei, D., Rosenberg, S., and Press, M. F. (2001) Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res. 61, 3212-3219 (Pubitemid 32691978)
11. Hori, M., Shimazaki, J., Inagawa, S., Itabashi, M., and Hori, M. (2000) Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement. Pathol. Int. 50, 786-792
12. Evdokiou, A., Atkins, G. J., Bouralexis, S., Hay, S., Raggatt, L. J., Cowled, P. A., Graves, S. E., Clayer, M., and Findlay, D. M. (2001) Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone. Int. J. Oncol. 19, 625-632
13. Tamborini, E., Della Torre, G., Lavarino, C., Azzarelli, A., Carpinelli, P., Pierotti, M. A., and Pilotti, S. (2001) Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int. J. Cancer 92, 790-796 (Pubitemid 32467366)
14. Matsumoto, R., Tada, M., Nozaki, M., Zhang, C. L., Sawamura, Y., and Abe, H. (1998) Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms. Cancer Res. 58, 609-613 (Pubitemid 28099465)
15. Jacob, A. G., O'Brien, D., Singh, R. K., Comiskey, D. F., Jr., Littleton, R. M., Mohammad, F., Gladman, J. T., Widmann, M. C., Jeyaraj, S. C., Bolinger, C., Anderson, J. R., Barkauskas, D. A., Boris-Lawrie, K., and Chandler, D. S. (2013) Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. Neoplasia 15, 1049-1063
16. Steinman, H. A., Burstein, E., Lengner, C., Gosselin, J., Pihan, G., Duckett, C. S., and Jones, S. N. (2004) An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J. Biol. Chem. 279, 4877-4886 (Pubitemid 38199083)
17. Fridman, J. S., Hernando, E., Hemann, M. T., de Stanchina, E., Cordon-Cardo, C., and Lowe, S. W. (2003) Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Res. 63, 5703-5706 (Pubitemid 37203378)
18. Volk, E. L., Fan, L., Schuster, K., Rehg, J. E., and Harris, L. C. (2009) The MDM2 - a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis. Mol. Cancer Res. 7, 863-869
19. Zheng, T., Wang, J., Zhao, Y., Zhang, C., Lin, M., Wang, X., Yu, H., Liu, L., Feng, Z., and Hu, W. (2013) SplicedMDM2isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis. Nat. Commun. 4, 2996
20. Chandler, D. S., Singh, R. K., Caldwell, L. C., Bitler, J. L., and Lozano, G. (2006) Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulatorsMDM2and MDM4. Cancer Res. 66, 9502-9508 (Pubitemid 44623648)
21. Dias, C. S., Liu, Y., Yau, A., Westrick, L., and Evans, S. C. (2006) Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability. Cancer Res. 66, 9467-9473 (Pubitemid 44623644)
22. Singh, R. K., Tapia-Santos, A., Bebee, T. W., and Chandler, D. S. (2009) Conserved sequences in the final intron of MDM2 are essential for the regulation of alternative splicing of MDM2 in response to stress. Exp. Cell Res. 315, 3419-3432
23. Rabenhorst, U., Beinoraviciute-Kellner, R., Brezniceanu, M. L., Joos, S., Devens, F., Lichter, P., Rieker, R. J., Trojan, J., Chung, H. J., Levens, D. L., and Zörnig, M. (2009) Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 50, 1121-1129
24. Malz, M., Weber, A., Singer, S., Riehmer, V., Bissinger, M., Riener, M. O., Longerich, T., Soll, C., Vogel, A., Angel, P., Schirmacher, P., and Breuhahn, K. (2009) Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology 50, 1130-1139
25. Singer, S., Malz, M., Herpel, E., Warth, A., Bissinger, M., Keith, M., Muley, T., Meister, M., Hoffmann, H., Penzel, R., Gdynia, G., Ehemann, V., Schnabel, P. A., Kuner, R., Huber, P., Schirmacher, P., and Breuhahn, K. (2009) Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res. 69, 2234-2243
26. Ma, J., Chen, M., Xia, S. K., Shu, W., Guo, Y., Wang, Y. H., Xu, Y., Bai, X. M., Zhang, L., Zhang, H., Zhang, M., Wang, Y. P., and Leng, J. (2013) Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression. Int. J. Oncol. 42, 1093-1104
27. Zhang, F., Tian, Q., and Wang, Y. (2013) Far upstream element-binding protein 1 (FUBP1) is overexpressed in human gastric cancer tissue compared to non-cancerous tissue. Onkologie 36, 650-655
28. Baumgarten, P., Harter, P. N., Tönjes, M., Capper, D., Blank, A. E., Sahm, F., von Deimling, A., Kolluru, V., Schwamb, B., Rabenhorst, U., Starzetz, T., Kögel, D., Rieker, R. J., Plate, K. H., Ohgaki, H., Radlwimmer, B., Zörnig, M., and Mittelbronn, M. (2014) Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity. Neuropathol. Appl. Neurobiol. 40, 205-216
29. Bettegowda, C., Agrawal, N., Jiao, Y., Sausen, M., Wood, L. D., Hruban, R. H., Rodriguez, F. J., Cahill, D. P., McLendon, R., Riggins, G., Velculescu, V. E., Oba-Shinjo, S. M., Marie, S. K., Vogelstein, B., Bigner, D., Yan, H., Papadopoulos, N., and Kinzler, K. W. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333, 1453-1455
30. Sahm, F., Koelsche, C., Meyer, J., Pusch, S., Lindenberg, K., Mueller, W., Herold-Mende, C., von Deimling, A., and Hartmann, C. (2012) CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol. 123, 853-860
31. Vindigni, A., Ochem, A., Triolo, G., and Falaschi, A. (2001) Identification of humanDNAhelicase V with the far upstream element-binding protein. Nucleic Acids Res. 29, 1061-1067 (Pubitemid 32186191)
32. Duncan, R., Bazar, L., Michelotti, G., Tomonaga, T., Krutzsch, H., Avigan, M., and Levens, D. (1994) A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 8, 465-480 (Pubitemid 24071186)
33. Braddock, D. T., Louis, J. M., Baber, J. L., Levens, D., and Clore, G. M. (2002) Structure and dynamics of KH domains from FBP bound to single-stranded DNA. Nature 415, 1051-1056 (Pubitemid 34193456)
34. Benjamin, L. R., Chung, H. J., Sanford, S., Kouzine, F., Liu, J., and Levens, D. (2008) Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein. Proc. Natl. Acad. Sci. U.S.A. 105, 18296-18301
35. Chien, H. L., Liao, C. L., and Lin, Y. L. (2011) FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication. J. Virol. 85, 4698-4706
36. Zheng, Y., and Miskimins, W. K. (2011) Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int. J. Biochem. Cell Biol. 43, 1641-1648
37. Huang, P. N., Lin, J. Y., Locker, N., Kung, Y. A., Hung, C. T., Lin, J. Y., Huang, H. I., Li, M. L., and Shih, S. R. (2011) Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res. 39, 9633-9648
38. Olanich, M. E., Moss, B. L., Piwnica-Worms, D., Townsend, R. R., and Weber, J. D. (2011) Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene 30, 77-86
39. Min, H., Turck, C. W., Nikolic, J. M., and Black, D. L. (1997) A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11, 1023-1036 (Pubitemid 27199881)
40. Rappsilber, J., Ryder, U., Lamond, A. I., and Mann, M. (2002) Large-scale proteomic analysis of the human spliceosome. Genome Res. 12, 1231-1245 (Pubitemid 41264425)
41. Li, H., Wang, Z., Zhou, X., Cheng, Y., Xie, Z., Manley, J. L., and Feng, Y. (2013) Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression. Proc. Natl. Acad. Sci. U.S.A. 110, E2687-2695
42. Mayeda, A., and Krainer, A. R. (1999) Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. Methods Mol. Biol 118, 309-314
43. Zhu, H., Hasman, R. A., Young, K. M., Kedersha, N. L., and Lou, H. (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Mol. Cell. Biol. 23, 5959-5971 (Pubitemid 37013077)
44. Wagner, E. J., and Garcia-Blanco, M. A. (2002) RNAi-mediated PTB depletion leads to enhanced exon definition. Mol. Cell 10, 943-949 (Pubitemid 35335648)
45. Jang, M., Park, B. C., Kang, S., Chi, S. W., Cho, S., Chung, S. J., Lee, S. C., Bae, K. H., and Park, S. G. (2009) Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene. Oncogene 28, 1529-1536
46. Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., and Schultz, N. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404
47. Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., and Schultz, N. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1
48. Back, S. H., Shin, S., and Jang, S. K. (2002) Polypyrimidine tract-binding proteins are cleaved by caspase-3 during apoptosis. J. Biol. Chem. 277, 27200-27209 (Pubitemid 34951736)
49. Izquierdo, J. M. (2008) Fas splicing regulation during early apoptosis is linked to caspase-mediated cleavage of U2AF65. Mol. Biol. Cell 19, 3299-3307
50. Weber, A., Kristiansen, I., Johannsen, M., Oelrich, B., Scholmann, K., Gunia, S., May, M., Meyer, H. A., Behnke, S., Moch, H., and Kristiansen, G. (2008) The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal but not in prostate and bladder cancer. BMC Cancer 8, 369
51. Ding, Z., Liu, X., Liu, Y., Zhang, J., Huang, X., Yang, X., Yao, L., Cui, G., and Wang, D. (2013) Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation. Mol. Carcinog. 10.1002/mc.22114
52. Zhou, Z., Licklider, L. J., Gygi, S. P., and Reed, R. (2002) Comprehensive proteomic analysis of the human spliceosome. Nature 419, 182-185 (Pubitemid 35025448)
53. Hastings, M. L., Allemand, E., Duelli, D. M., Myers, M. P., and Krainer, A. R. (2007) Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65). PLoS One 2, e538
54. Page-McCaw, P. S., Amonlirdviman, K., and Sharp, P. A. (1999) PUF60: a novel U2AF65-related splicing activity. RNA 5, 1548-1560
55. Liu, J., He, L., Collins, I., Ge, H., Libutti, D., Li, J., Egly, J. M., and Levens, D. (2000) The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol. Cell 5, 331-341 (Pubitemid 30628091)
56. Liu, J., Chung, H. J., Vogt, M., Jin, Y., Malide, D., He, L., Dundr, M., and Levens, D. (2011) JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J. 30, 846-858
57. Atanassov, B. S., and Dent, S. Y. (2011) USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep. 12, 924-930
58. Xiao, J., Zhang, Z., Chen, G. G., Zhang, M., Ding, Y., Fu, J., Li, M., and Yun, J. P. (2009) Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability. Cell Cycle 8, 889-895
59. Colombo, E., Bonetti, P., Lazzerini Denchi, E., Martinelli, P., Zamponi, R., Marine, J. C., Helin, K., Falini, B., and Pelicci, P. G. (2005) Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol. Cell. Biol. 25, 8874-8886 (Pubitemid 41429079)